Result: Impact of accelerometer epoch summary measure on associations between physical activity and all-cause mortality in Whitehall II and UK Biobank.
Int J Epidemiol. 2005 Apr;34(2):251-6. (PMID: 15576467)
J Chiropr Med. 2016 Jun;15(2):155-63. (PMID: 27330520)
Eur J Prev Cardiol. 2025 Jan 6;32(1):10-19. (PMID: 39276370)
JMIR Mhealth Uhealth. 2022 Jul 22;10(7):e38077. (PMID: 35867392)
Pediatr Exerc Sci. 2018 Nov 1;30(4):450-456. (PMID: 30304982)
Br J Sports Med. 2014 Jul;48(13):1019-23. (PMID: 24782483)
Sci Rep. 2022 Jul 13;12(1):11958. (PMID: 35831446)
Am J Epidemiol. 2014 Mar 15;179(6):781-90. (PMID: 24500862)
PLoS Med. 2015 Mar 31;12(3):e1001779. (PMID: 25826379)
PLoS One. 2017 Feb 1;12(2):e0169649. (PMID: 28146576)
J Meas Phys Behav. 2019 Dec;2(4):268-281. (PMID: 34308270)
Nat Med. 2020 Sep;26(9):1385-1391. (PMID: 32807930)
Scand J Med Sci Sports. 2023 Mar;33(3):267-282. (PMID: 36326758)
J Sport Health Sci. 2025 Dec;14:100970. (PMID: 39181446)
EClinicalMedicine. 2022 Dec 13;55:101773. (PMID: 36568684)
Sci Rep. 2019 Dec 3;9(1):18235. (PMID: 31796778)
Med Sci Sports Exerc. 2021 Nov 1;53(11):2455-2464. (PMID: 34115727)
PLoS One. 2013 Apr 23;8(4):e61691. (PMID: 23626718)
Br J Sports Med. 2020 Dec;54(24):1468-1473. (PMID: 33239352)
Med Sci Sports Exerc. 2018 Jun;50(6):1323-1332. (PMID: 29360664)
Med Sci Sports Exerc. 2022 Sep 1;54(9):1582-1590. (PMID: 35666160)
Eur Heart J. 2022 Dec 7;43(46):4789-4800. (PMID: 36302445)
PLoS One. 2024 Sep 17;19(9):e0309931. (PMID: 39288135)
Lancet. 1991 Jun 8;337(8754):1387-93. (PMID: 1674771)
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034. (PMID: 28641372)
Br J Sports Med. 2020 Dec;54(24):1451-1462. (PMID: 33239350)
Sensors (Basel). 2024 May 10;24(10):. (PMID: 38793873)
J Appl Physiol (1985). 2014 Oct 1;117(7):738-44. (PMID: 25103964)
Clin Physiol Funct Imaging. 2015 Jan;35(1):64-70. (PMID: 24393233)
Sci Rep. 2024 Apr 4;14(1):7927. (PMID: 38575636)
Further Information
Accelerometer data are commonly reduced into epoch summary measures (ESMs) for analysis, e.g. ENMO (Euclidean Norm Minus One), MAD (Mean Amplitude Deviation), MIMS (Monitor Independent Movement Summary) or Counts. We compared associations with all-cause mortality of the volume and intensity of physical activity when derived from those four measures in the Whitehall II and UK Biobank cohorts. Volume (Average Acceleration, AvAcc) and intensity (Intensity Gradient, IG) were derived from each ESM. Associations with mortality were estimated using Cox models. 3733 (25.1% female, median age 68.3 years) and 89,848 (56.4% female, 63.5 years) participants were included from Whitehall II and UK Biobank, respectively. Median (IQR) follow-up was 11.0 (10.7, 11.3) and 8.0 (7.5, 8.5) years, with 563 (15.1%) and 3656 (4.1%) deaths. Associations with mortality were largely consistent between ESMs with the lowest mortality risk for those high (above the median) in both AvAcc and IG (Whitehall: HR = 0.59-0.68; Biobank: 0.55-0.61, reference: low/low), and IG associated with lower mortality risk, irrespective of AvAcc. AvAcc was associated with lower mortality irrespective of IG in Biobank only. In conclusion, associations of AvAcc and IG with mortality are broadly consistent across common ESMs, supporting comparability of activity-health findings across studies using different ESMs.
(© 2025. The Author(s).)
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: In the Whitehall II study, written, informed consent from participants was obtained at each contact. Research ethics approvals were renewed at each wave; the most recent approval was granted by the National Health Service (NHS) London-Harrow Research Ethics Committee (reference number 85/0938). UK Biobank has full ethical approval from the NHS National Research Ethics Service (16/NW/0274) and all participants gave written informed consent prior to data collection.